
ZYME vs GPCR
$ZYME vs $GPCR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ZYME vs GPCR: the quick read
- ·ZYME is the larger company by market cap ($1.81B vs $1.79B).
- ·GPCR has been more active on our scanner (138 vs 66 alerts in 30 days).
- ·ZYME has the smaller float (45.7M vs 204.0M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 138 and 66 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ZYME and GPCR on TheDesperateTrader.
- Is ZYME or GPCR the better stock?
- "Better" depends on your goal, and these two are not alike. ZYME is the larger company by market cap ($1.81B vs $1.79B). GPCR has been more active on our scanner (138 vs 66 alerts in 30 days). ZYME has the smaller float (45.7M vs 204.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ZYME and GPCR?
- The differences that matter: they are not in the same business - ZYME is pharmaceutical preparations and GPCR is pharmaceutical preparations; they are similar in size ($1.81B vs $1.79B); they trade at very different share prices ($25.26 vs $25.69); ZYME sits at 60% of its 52-week range against 1% for GPCR; our scanner flagged ZYME 66 times in the last 30 days against 138 for GPCR. Everything above is measured from the latest completed session and SEC filings.
- Which of ZYME and GPCR is more active right now?
- Right now ZYME is at about 1.5x its normal volume and GPCR is at about 0.7x, so ZYME is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ZYME or GPCR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ZYME and GPCR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.